{"id":253790,"date":"2026-05-22T23:40:23","date_gmt":"2026-05-22T23:40:23","guid":{"rendered":"https:\/\/www.europesays.com\/se\/253790\/"},"modified":"2026-05-22T23:40:23","modified_gmt":"2026-05-22T23:40:23","slug":"ema-rekommenderar-godkannande-av-novo-nordisks-wegovys-orala-piller","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/253790\/","title":{"rendered":"EMA rekommenderar godk\u00e4nnande av Novo Nordisks Wegovys orala piller"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Europeiska l\u00e4kemedelsmyndigheten EMA rekommenderar godk\u00e4nnande f\u00f6r danska l\u00e4kemedelsbolaget Novo Nordisks viktminskningspiller Wegovy.\n <\/p>\n<p>Detta banar v\u00e4g f\u00f6r att bli det f\u00f6rsta orala viktminskningsl\u00e4kemedlet i Europa, f\u00f6re den amerikanska rivalen Eli Lilly, rapporterar Reuters.\n <\/p>\n<p>Rekommendationen kommer samtidigt som konkurrensen mellan Novo och Lilly intensifieras, d\u00e4r b\u00e5da f\u00f6retagen str\u00e4var efter att \u00f6ka sin andel av den v\u00e4xande marknaden f\u00f6r l\u00e4kemedel mot fetma, som analytiker f\u00f6rv\u00e4ntar sig att n\u00e5 150 miljarder dollar \u00e5rligen under det kommande decenniet, genom att expandera till orala behandlingar.\n <\/p>\n<p>Novo lanserade orala piller i USA tidigare i \u00e5r efter att ha f\u00e5tt FDA-godk\u00e4nnande, vilket gav bolaget en tidig start. Lillys viktminskningspiller, Foundayo, lanserades i april efter att ha godk\u00e4nts i USA.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Henrik \u00d6hlin<br \/>\n <br class=\"col-start-2\"\/><br \/>\n henrik.ohlin@finwire.se, 0703-21 06 99<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Europeiska l\u00e4kemedelsmyndigheten EMA rekommenderar godk\u00e4nnande f\u00f6r danska l\u00e4kemedelsbolaget Novo Nordisks viktminskningspiller Wegovy. Detta banar v\u00e4g f\u00f6r att bli&hellip;\n","protected":false},"author":2,"featured_media":253791,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,70,71,6631,6456,6457,34,31,33,32,30],"class_list":["post-253790","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-economy","tag-ekonomi","tag-eli-lilly","tag-novo-nordisk-adr","tag-novo-nordisk-b","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116620874388379878","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/253790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=253790"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/253790\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/253791"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=253790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=253790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=253790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}